dc.creator |
Hattersley, Andrew T. |
|
dc.creator |
Thorens, B. |
|
dc.date |
2016-08-09T14:36:03Z |
|
dc.date |
2016-08-09T14:36:03Z |
|
dc.date |
2015-09-03 |
|
dc.date.accessioned |
2023-02-17T19:48:11Z |
|
dc.date.available |
2023-02-17T19:48:11Z |
|
dc.identifier |
Type 2 Diabetes, SGLT2 Inhibitors, and Glucose Secretion. 2015, 373 (10):974-6 N. Engl. J. Med. |
|
dc.identifier |
1533-4406 |
|
dc.identifier |
26332554 |
|
dc.identifier |
10.1056/NEJMcibr1506573 |
|
dc.identifier |
http://hdl.handle.net/11287/618135 |
|
dc.identifier |
The New England Journal of Medicine |
|
dc.identifier.uri |
http://localhost:8080/xmlui/handle/CUHPOERS/242008 |
|
dc.language |
en |
|
dc.publisher |
NEJM |
|
dc.relation |
http://www.nejm.org/doi/abs/10.1056/NEJMcibr1506573?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed |
|
dc.rights |
Archived with thanks to The New England journal of medicine |
|
dc.subject |
Wessex Classification Subject Headings::Endocrinology::Diabetes |
|
dc.subject |
Wessex Classification Subject Headings::Oncology. Pathology.::Genetics |
|
dc.title |
Type 2 Diabetes, SGLT2 Inhibitors, and Glucose Secretion. |
|
dc.type |
Journal Article |
|
dc.type |
Published |
|